Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease C O'Callaghan, F Hezemans, N Subramaniam, R Ye, K Tsvetanov, ... | | 2024 |
In-vivo parcellation of human subcortex by multi-modal MRI T Ali, J Lv, M Kassem, A D'Souza, C O’Callaghan, M Dalton, F Calamante | | 2024 |
Abnormal higher-order network interactions in Parkinson’s disease visual hallucinations JB Tan, EJ Müller, IF Orlando, NL Taylor, DS Margulies, J Szeto, ... Brain 147 (2), 458-471, 2024 | 1 | 2024 |
Noradrenergic modulation of saccades in Parkinson’s disease IF Orlando, FH Hezemans, R Ye, AG Murley, N Holland, R Regenthal, ... medRxiv, 2024.01. 04.24300879, 2024 | | 2024 |
An attentional and working memory theory of hallucination vulnerability in frontotemporal dementia EM Devenney, NY Tse, C O’Callaghan, F Kumfor, RM Ahmed, J Caga, ... Brain Communications 6 (3), fcae123, 2024 | | 2024 |
Sleep spindle architecture associated with distinct clinical phenotypes in older adults at risk for dementia IF Orlando, C O’Callaghan, A Lam, AC McKinnon, JBC Tan, ... Molecular Psychiatry, 1-10, 2023 | | 2023 |
Locus Coeruleus Integrity Is Linked to Response Inhibition Deficits in Parkinson's Disease and Progressive Supranuclear Palsy R Ye, FH Hezemans, C O'Callaghan, KA Tsvetanov, C Rua, PS Jones, ... Journal of Neuroscience 43 (42), 7028-7040, 2023 | 3 | 2023 |
Understanding visual hallucinations: a new synthesis D Collerton, J Barnes, NJ Diederich, R Dudley, K Friston, CG Goetz, ... Neuroscience & Biobehavioral Reviews 150, 105208, 2023 | 9 | 2023 |
Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing IF Orlando, JM Shine, TW Robbins, JB Rowe, C O’Callaghan Neuroscience & Biobehavioral Reviews, 105167, 2023 | 17 | 2023 |
Zero the hero: evidence for involvement of the ventromedial prefrontal cortex in affective bias for free items V Lenglin, S Wong, C O'callaghan, S Erzinçlioğlu, M Hornberger, ... Cortex 160, 24-42, 2023 | | 2023 |
Understanding the effects of serotonin in the brain through its role in the gastrointestinal tract JM Shine, C O’Callaghan, IC Walpola, G Wainstein, N Taylor, J Aru, ... Brain 145 (9), 2967-2981, 2022 | 28 | 2022 |
Locus coeruleus integrity from 7 T MRI relates to apathy and cognition in Parkinsonian disorders R Ye, C O'Callaghan, C Rua, FH Hezemans, N Holland, M Malpetti, ... Movement Disorders 37 (8), 1663-1672, 2022 | 35 | 2022 |
Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes FH Hezemans, N Wolpe, C O’Callaghan, R Ye, C Rua, PS Jones, ... PLoS Computational Biology 18 (5), e1010079, 2022 | 21 | 2022 |
Structural and Functional Correlates of Hallucinations and Illusions in Parkinson’s Disease A Marques, NL Taylor, D Roquet, S Beze, C Chassain, B Pereira, ... Journal of Parkinson's Disease 12 (1), 397-409, 2022 | 10 | 2022 |
Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease LA Morris, C O'Callaghan, C Le Heron Movement disorders: official journal of the Movement Disorder Society, 2022 | 16 | 2022 |
Reduced locus coeruleus integrity linked to response inhibition deficits in parkinsonian disorders R Ye, FH Hezemans, C O’Callaghan, KA Tsvetanov, C Rua, PS Jones, ... medRxiv, 2021.10. 14.21264996, 2021 | 2 | 2021 |
Limbic hypoconnectivity in idiopathic REM sleep behaviour disorder with impulse control disorders A Marques, D Roquet, E Matar, NL Taylor, B Pereira, C O’Callaghan, ... Journal of Neurology 268, 3371-3380, 2021 | 12 | 2021 |
Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson’s disease C O’Callaghan, FH Hezemans, R Ye, C Rua, PS Jones, AG Murley, ... Brain 144 (8), 2513-2526, 2021 | 61 | 2021 |
Anterior‐posterior electrophysiological activity characterizes Parkinsonian visual misperceptions AJ Muller, JM Shine, CE Rolle, K Chitty, JM Hall, GM Halliday, ... Neurology and Clinical Neuroscience 9 (4), 312-318, 2021 | 2 | 2021 |
Substantia nigra ferric overload and neuromelanin loss in Parkinson’s disease measured with 7T MRI C Rua, C O’Callaghan, R Ye, FH Hezemans, L Passamonti, PS Jones, ... medRxiv, 2021.04. 13.21255416, 2021 | 3 | 2021 |